(Q34125431)

31 July 2017

1 reference

title

Clinical potentials of neuropeptide Y family of hormones (English)

1 reference

31 July 2017

author name string

Ambikaipakan Balasubramaniam

series ordinal

1

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 April 2002

1 reference

The American Journal of Surgery

31 July 2017

published in

1 reference

31 July 2017

volume

183

1 reference

31 July 2017

issue

4

1 reference

31 July 2017

page(s)

430-434

1 reference

Neuropeptide Y: complete amino acid sequence of the brain peptide

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900803-6

Isolation and characterization of peptide YY (PYY), a candidate gut hormone that inhibits pancreatic exocrine secretion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900803-6

Isolation and Characterization of Chicken Insulin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900803-6

Neuropeptide Y family of hormones: receptor subtypes and antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900803-6

Multiple receptors for the pancreatic polypeptide (PP-fold) family: physiological implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900803-6

Neuropeptide Y feeding receptors: are multiple subtypes involved?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900803-6

Hypothalamic concentration and release of neuropeptide Y into microdialysates is reduced in anorectic tumor-bearing rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900803-6

The role of neuropeptide Y in the antiobesity action of the obese gene product

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900803-6

Attenuation of the obesity syndrome of ob/ob mice by the loss of neuropeptide Y.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900803-6

[D-Trp(34)] neuropeptide Y is a potent and selective neuropeptide Y Y(5) receptor agonist with dramatic effects on food intake

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900803-6

Cardiovascular response, feeding behavior and locomotor activity in mice lacking the NPY Y1 receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900803-6

Role of the Y5 neuropeptide Y receptor in feeding and obesity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900803-6

Neuropeptide Y and limbic seizures.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900803-6

Role of the Y5 neuropeptide Y receptor in limbic seizures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900803-6

Neuropeptide Y: emerging evidence for a functional role in seizure modulation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900803-6

Cardiovascular effects of neuropeptide Y: receptor interactions and cellular mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900803-6

Neuropeptide Y prevents the blood pressure fall induced by endotoxin in conscious rats with adrenal medullectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900803-6

Neuropeptide Y stimulates hypertrophy of adult ventricular cardiomyocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900803-6

Neuropeptide Y (NPY) potentiates phenylephrine-induced mitogen-activated protein kinase activation in primary cardiomyocytes via NPY Y5 receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900803-6

Peptide YY and neuropeptide Y: two peptides intimately involved in electrolyte homeostasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900803-6

Peptidergic regulation of intestinal ion transport. A major role for neuropeptide Y and the pancreatic polypeptides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900803-6

Peptide YY is a physiological regulator of water and electrolyte absorption in the canine small bowel in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900803-6

Peptide YY augments postprandial small intestinal absorption in the conscious dog.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900803-6

Neuropeptide Y (NPY) and peptide YY (PYY) inhibit prostaglandin E2-induced intestinal fluid and electrolyte secretion in the rat jejunum in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900803-6

Preservation of intestine protein by peptide YY during total parenteral nutrition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900803-6

Pancreatic peptide YY mRNA levels increase during adaptation after small intestinal resection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900803-6

Structure-activity studies including a Psi(CH(2)-NH) scan of peptide YY (PYY) active site, PYY(22-36), for interaction with rat intestinal PYY receptors: development of analogues with potent in vivo activity in the intestine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900803-6

The peptide YY-preferring receptor mediating inhibition of small intestinal secretion is a peripheral Y(2) receptor: pharmacological evidence and molecular cloning

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900803-6

A Novel Synthetic Analog of Peptide YY, BIM-43004, Given Intraluminally, Is Proabsorptive

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900803-6

Attenuation of allergen-evoked nasal responses by local pretreatment with exogenous neuropeptide Y in atopic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900803-6

Influence of TASP-V, a novel neuropeptide Y (NPY) Y2 agonist, on nasal and bronchial responses evoked by histamine in anaesthetized pigs and in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900803-6

A novel neuropeptide Y analog, N-acetyl [Leu28,Leu31]neuropeptide Y-(24-36), with functional specificity for the presynaptic (Y2) receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900803-6

Y2 receptors decrease human pancreatic cancer growth and intracellular cyclic adenosine monophosphate levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900803-6

10.1016/S0002-9610(02)00803-6

7 January 2021

Identifiers

DOI

1 reference

31 July 2017

1 reference